Joseph Woodard
Chief Tech/Sci/R&D Officer at IMUGENE LIMITED
Joseph Woodard active positions
| Companies | Position | Start | End |
|---|---|---|---|
| IMUGENE LIMITED | Chief Tech/Sci/R&D Officer | 03/09/2023 | - |
Career history of Joseph Woodard
Former positions of Joseph Woodard
| Companies | Position | Start | End |
|---|---|---|---|
| BELLICUM PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 10/01/2017 | 31/10/2019 |
Immune-Onc Therapeutics, Inc.
 Immune-Onc Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Immune-Onc Therapeutics, Inc. operates as a biopharmaceutical company focused on developing innovative therapeutic antibodies for cancer treatment. The company was founded by Charlene Liao and Gui-Liang Yu in 2016 and is headquartered in Palo Alto, CA. | Chief Tech/Sci/R&D Officer | - | - |
Training of Joseph Woodard
| The University of North Carolina at Charlotte | Undergraduate Degree |
| UNC School of Medicine | Doctorate Degree |
Statistics
International
| United States | 5 |
| Australia | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 3 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| IMUGENE LIMITED | Health Technology |
| Private companies | 2 |
|---|---|
Bellicum Pharmaceuticals, Inc.
 Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. The firm uses its proprietary chemical induction of dimerization that controls components of the immune system in real time. Its product candidates include BPX-601, BPX-603, and Rivo-cel (rivogenlecleucel, formerly known as BPX-501). The company was founded by Kevin M. Slawin and David M. Spencer on July 14, 2004 and is headquartered in Houston, TX. | Health Technology |
Immune-Onc Therapeutics, Inc.
Immune-Onc Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Immune-Onc Therapeutics, Inc. operates as a biopharmaceutical company focused on developing innovative therapeutic antibodies for cancer treatment. The company was founded by Charlene Liao and Gui-Liang Yu in 2016 and is headquartered in Palo Alto, CA. | Health Technology |
- Stock Market
- Insiders
- Joseph Woodard
- Experience